Clinical Trials — Gastrointestinal Cancer

                                                                                           Click on trial for description and contact information.                                                            

A Phase 2, Randomized, Double-Blind, Placebo Controlled Study of AMG 386 in Combination with FOLFIRI in Subjects with Previously Treated Metastatic Colorectal Carcinoma

A Phase I Open-Label, Sequential Dose Escalation Study Investigating the Safety, Tolerability, and Pharmacokinetics of Intravenous Lipotecan® (TLC388 HCl for Injection) when administered to Patients with Advanced Solid Tumors

 

For more information or to refer a patient, contact:

Pam Bourbo, RN, MPH, OCN, CCRC

manager

Cancer Clinical Research Unit

(706) 721-2730

pbourbo@mcg.edu

[Back to Top]

Revised September 16, 2009.  Please send comments, suggestions or questions about this page to Cancer Team, cancer@mcg.edu.